Director for Bed Bath & Beyond (BBBY) buys 20,000 shares via trust

Rhea-AI Filing Summary

Bed Bath & Beyond director Joseph J. Tabacco Jr. reported an open-market purchase of 20,000 shares of Common Stock at a weighted average price of $5.11 per share. The shares were bought on March 10, 2026 in multiple trades between $5.07 and $5.13 per share.

The purchase was made indirectly through the Joseph Tabacco and Peggy Schmidt Revocable Trust, where he is trustee and beneficiary. After this transaction, the trust held 167,209 shares, and he also held 11,506 shares directly.

The filing also notes previously issued warrants from October 7, 2025, covering 1,150 shares directly and 14,720 shares indirectly, each exercisable for one share of common stock at an exercise price of $15.50 per warrant, with an expiration date of October 7, 2026.

Insights

Insider trading and governance analyst

Director-linked trust buys 20,000 BBBY shares; warrants add optional upside.

Director Joseph J. Tabacco Jr., through the Joseph Tabacco and Peggy Schmidt Revocable Trust, executed an open-market purchase of 20,000 Bed Bath & Beyond shares at a weighted average of $5.11. This lifts the trust’s holdings to 167,209 shares, while he also holds 11,506 shares directly.

The transaction is classified as a net buy with no reported sales, suggesting a routine increase in exposure rather than profit-taking. The filing also records warrants issued on October 7, 2025 covering 1,150 shares directly and 14,720 shares indirectly at a $15.50 exercise price, expiring on October 7, 2026. These instruments provide additional, higher-strike leverage that becomes relevant only if the stock trades above the exercise price.

Given the scale of reported ownership and absence of dispositions, the activity appears incremental rather than transformative. The informational value lies mainly in the director-associated trust choosing to add common shares while retaining previously distributed warrants.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TABACCO JOSEPH J JR

(Last) (First) (Middle)

433 ASCENSION WAY

3RD FLOOR

(Street)

MURRAY UT 84123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BED BATH & BEYOND, INC. [ BBBY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		P		20,000	A	$5.11(1)	167,209	I	Held by the Joseph Tabacco and Peggy Schmidt Revocable Trust.(2)
Common Stock								11,506	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Warrant	$15.5	10/07/2025		A		1,150(3)		12/03/2025	10/07/2026	Common Stock	1,150	$0	1,150	D
Common Stock Warrant	$15.5	10/07/2025		A		14,720(3)		12/03/2025	10/07/2026	Common Stock	14,720	$0	14,720	I	Held by the Joseph Tabacco and Peggy Schmidt Revocable Trust.(2)

Explanation of Responses:

1. $5.11 is the weighted average purchase price for the 20,000 shares purchased on March 10, 2026. The shares were purchased in multiple transactions at prices ranging from $5.07 to $5.13 per share, inclusive. The reporting person will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

2. Mr. Tabacco is trustee and beneficiary of the Joseph Tabacco and Peggy Schmidt Revocable Trust.

3. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.

	/s/ Christina Wheeler, Attorney-in-Fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Bed Bath & Beyond (BBBY) director Joseph Tabacco buy in this Form 4?

He reported an open-market purchase of 20,000 shares of Common Stock on March 10, 2026 at a weighted average price of $5.11 per share, with individual trade prices ranging from $5.07 to $5.13.

How are the new Bed Bath & Beyond (BBBY) shares held after Joseph Tabacco’s purchase?

The 20,000 purchased shares are held indirectly by the Joseph Tabacco and Peggy Schmidt Revocable Trust. Following the transaction, the trust held 167,209 common shares, while he also reported 11,506 shares held directly in his own name.

What warrants linked to Bed Bath & Beyond (BBBY) does Joseph Tabacco report in this filing?

He reports warrants originally issued on October 7, 2025, covering 1,150 underlying shares directly and 14,720 underlying shares indirectly. Each warrant allows purchase of one Bed Bath & Beyond common share at an exercise price of $15.50 per warrant.

Were the Bed Bath & Beyond (BBBY) warrants a new grant to Joseph Tabacco?

No, the warrants were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. The filing notes this distribution was exempt from immediate Section 16 reporting, so it appears here for historical completeness.

Does this Bed Bath & Beyond (BBBY) Form 4 show any insider share sales by Joseph Tabacco?

The transaction summary shows one open-market purchase totaling 20,000 shares and no reported sales. Net buy-sell activity is described as a net buy of 20,000 shares, with no dispositions, gifts, or tax-withholding entries disclosed.

How many Bed Bath & Beyond (BBBY) shares and warrants does Joseph Tabacco report controlling?

After the reported transactions, he lists 167,209 common shares held indirectly via the revocable trust and 11,506 shares held directly, plus warrants over 1,150 underlying shares directly and 14,720 underlying shares indirectly at a $15.50 exercise price.